Rhea-AI Summary
BlossomHill Therapeutics, Inc. (BLSM) reported the initial insider holdings of its Chief Financial Officer, Jason A. Keyes, on a Form 3. He holds an employee stock option covering 175,417 shares of common stock at an exercise price of $6.28 per share, expiring on May 5, 2035. The option is noted as immediately exercisable and is held as a direct ownership position.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-- %
Tags
FAQ
How many BlossomHill Therapeutics (BLSM) SEC filings are available on StockTitan?
StockTitan tracks 21 SEC filings for BlossomHill Therapeutics (BLSM). Each filing includes AI-generated summaries, impact scoring, and sentiment analysis.
When was the most recent SEC filing for BlossomHill Therapeutics (BLSM)?
The most recent SEC filing for BlossomHill Therapeutics (BLSM) was filed on August 6, 2026.